Clinical Cancer Research, Vol 4, Issue 9 2141-2146, Copyright © 1998 by American Association for Cancer Research

ARTICLES

Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood

Y Ko, M Klinz, G Totzke, I Gouni-Berthold, A Sachinidis and H Vetter
Medizinische Universitats-Poliklinik, Bonn, Germany.

To examine the limitations of reverse transcription (RT)-PCR for the detection of circulating tumor cells in blood, we established a RT-PCR for carcinoembryonic antigen (CEA). Whole blood (10(7) nucleated cells) was mixed with cells from the colon cancer cell line LS174T (concentrations ranging from 0 to 10(6) cells). RT-PCR was performed to detect CEA mRNA in blood under various conditions. Healthy blood donors (n = 24) were examined by the established method for detecting CEA mRNA in blood. We were able to show that there is a detection limit for RT-PCR of 10 tumor cells in total and of 1 tumor cell in 10(5) nucleated cells. To obtain these results, a high number of PCR cycles (first PCR, 30 cycles; nested PCR, 45 cycles) was required. Under these PCR conditions, we found a positive PCR signal in 33% of healthy blood donors (n = 8). To overcome this problem, we reduced the nested PCR to 35 cycles. At that point, none of the controls showed a positive signal for CEA, and there was a subsequent decrease of the detection limit to 1 tumor cell in 10(2)-10(3) nucleated cells, lower than the detection limit of an immunocytological examination (1 tumor cell in 10(4) nucleated cells). When the amplification was performed with the tumor cells only and with no nucleated blood cells present, under exactly the same conditions, there was still a detection limit of 1 tumor cell in 106 nucleated cells. Our data clearly show that there is a severe loss of expected sensitivity of RT-PCR if it is performed in blood or nucleated blood cells. We conclude that PCR for CEA mRNA expression is not more sensitive than immunocytology and is, furthermore, plagued by the problem of a high percentage of false positive results.

This article has been cited by other articles:

				G. Giribaldi, S. Procida, D. Ulliers, F. Mannu, R. Volpatto, G. Mandili, L. Fanchini, O. Bertetto, G. Fronda, L. Simula, et al. Specific Detection of Cytokeratin 20-Positive Cells in Blood of Colorectal and Breast Cancer Patients by a High Sensitivity Real-Time Reverse Transcriptase-Polymerase Chain Reaction Method J. Mol. Diagn., February 1, 2006; 8(1): 105 - 112. [Abstract] [Full Text] [PDF]

				S. Mosolits, G. Ullenhag, and H. Mellstedt Therapeutic vaccination in patients with gastrointestinal malignancies. A review of immunological and clinical results Ann. Onc., June 1, 2005; 16(6): 847 - 862. [Abstract] [Full Text] [PDF]

				S. B. Ho, A. Hyslop, R. Albrecht, A. Jacobson, M. Spencer, D. A. Rothenberger, G. A. Niehans, J. D'Cunha, and R. A. Kratzke Quantification of Colorectal Cancer Micrometastases in Lymph Nodes by Nested and Real-Time Reverse Transcriptase-PCR Analysis for Carcinoembryonic Antigen Clin. Cancer Res., September 1, 2004; 10(17): 5777 - 5784. [Abstract] [Full Text] [PDF]

				J.-Y. Pierga, C. Bonneton, A. Vincent-Salomon, P. de Cremoux, C. Nos, N. Blin, P. Pouillart, J.-P. Thiery, and H. Magdelenat Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients Clin. Cancer Res., February 15, 2004; 10(4): 1392 - 1400. [Abstract] [Full Text] [PDF]

				G. Castaldo, R. Tomaiuolo, A. Sanduzzi, A. Ponticiello, I. Marchetiello, and F. Salvatore Carcinoembryonic antigen mRNA analysis detects micrometastatic cells in blood from lung cancer patients Eur. Respir. J., September 1, 2003; 22(3): 418 - 421. [Abstract] [Full Text] [PDF]

				B. Taback, A. E. Giuliano, N. M. Hansen, F. R. Singer, S. Shu, and D. S. B. Hoon Detection of Tumor-Specific Genetic Alterations in Bone Marrow from Early-Stage Breast Cancer Patients Cancer Res., April 15, 2003; 63(8): 1884 - 1887. [Abstract] [Full Text] [PDF]

				M. Koike, K. Hibi, Y. Kasai, K. Ito, S. Akiyama, and A. Nakao Molecular Detection of Circulating Esophageal Squamous Cell Cancer Cells in the Peripheral Blood Clin. Cancer Res., September 1, 2002; 8(9): 2879 - 2882. [Abstract] [Full Text] [PDF]

				F A Vlems, J H S Diepstra, I M H A Cornelissen, T J M Ruers, M J L Ligtenberg, C J A Punt, J H J M van Krieken, T. Wobbes, and G N P van Muijen Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue Mol. Pathol., June 1, 2002; 55(3): 156 - 163. [Abstract] [Full Text] [PDF]

				P. Kufer, A. Zippelius, R. Lutterbuse, I. Mecklenburg, T. Enzmann, A. Montag, D. Weckermann, B. Passlick, N. Prang, P. Reichardt, et al. Heterogeneous Expression of MAGE-A Genes in Occult Disseminated Tumor Cells: A Novel Multimarker Reverse Transcription-Polymerase Chain Reaction for Diagnosis of Micrometastatic Disease Cancer Res., January 1, 2002; 62(1): 251 - 261. [Abstract] [Full Text] [PDF]

				F. Guadagni, J. Kantor, S. Aloe, M. D. Carone, A. Spila, R. D’Alessandro, M. R. Abbolito, M. Cosimelli, F. Graziano, F. Carboni, et al. Detection of Blood-borne Cells in Colorectal Cancer Patients by Nested Reverse Transcription-Polymerase Chain Reaction for Carcinoembryonic Antigen Messenger RNA: Longitudinal Analyses and Demonstration of Its Potential Importance as an Adjunct to Multiple Serum Markers Cancer Res., March 1, 2001; 61(6): 2523 - 2532. [Abstract] [Full Text]

				M. Koch, J. Weitz, P. Kienle, A. Benner, F. Willeke, T. Lehnert, C. Herfarth, and M. von Knebel Doeberitz Comparative Analysis of Tumor Cell Dissemination in Mesenteric, Central, and Peripheral Venous Blood in Patients With Colorectal Cancer Arch Surg, January 1, 2001; 136(1): 85 - 89. [Abstract] [Full Text] [PDF]

				S. Hosch, J. Kraus, P. Scheunemann, J. R. Izbicki, C. Schneider, U. Schumacher, K. Witter, M. R. Speicher, and K. Pantel Malignant Potential and Cytogenetic Characteristics of Occult Disseminated Tumor Cells in Esophageal Cancer Cancer Res., December 1, 2000; 60(24): 6836 - 6840. [Abstract] [Full Text]

				J.-C. Goeminne, T. Guillaume, M. Federico, R. Sabbatini, M. Morselli, R. Depenni, K. Cagossi, M. Luppi, G. Torelli, and V. Silingardi Detection of Circulating Tumor by Reverse Transcriptase Polymerase Chain Reaction J. Clin. Oncol., September 17, 2000; 18(17): 3196 - 3197. [Full Text] [PDF]

				Z. A. J. Khan, S. K. Jonas, N. Le-Marer, H. Patel, R. Q. Wharton, A. Tarragona, A. Ivison, and T. G. Allen-Mersh p53 Mutations in Primary and Metastatic Tumors and Circulating Tumor Cells from Colorectal Carcinoma Patients Clin. Cancer Res., September 1, 2000; 6(9): 3499 - 3504. [Abstract] [Full Text]

				J.-J. Lu, Y. Kakehi, T. Takahashi, X.-X. Wu, T. Yuasa, T. Yoshiki, Y. Okada, T. Terachi, and O. Ogawa Detection of Circulating Cancer Cells by Reverse Transcription-Polymerase Chain Reaction for Uroplakin II in Peripheral Blood of Patients with Urothelial Cancer Clin. Cancer Res., August 1, 2000; 6(8): 3166 - 3171. [Abstract] [Full Text]

				Antonella De Luca, S. Pignata, A. Casamassimi, A. D’Antonio, C. Gridelli, A. Rossi, F. Cremona, V. Parisi, Andrea De Matteis, and N. Normanno Detection of Circulating Tumor Cells in Carcinoma Patients by a Novel Epidermal Growth Factor Receptor Reverse Transcription-PCR Assay Clin. Cancer Res., April 1, 2000; 6(4): 1439 - 1444. [Abstract] [Full Text]

				K. Pantel, R. J. Cote, and O. Fodstad Detection and Clinical Importance of Micrometastatic Disease J Natl Cancer Inst, July 7, 1999; 91(13): 1113 - 1124. [Abstract] [Full Text] [PDF]